Epidermodysplasia Verruciformis: Genetic Heterogeneity and EVER1 and EVER2 Mutations Revealed by Genome-Wide Analysis

Journal of Investigative Dermatology

Volumn 139, Issue 1, 2019, Pages 241-244

  Youssefian, Leila ^a,b   Vahidnezhad, Hassan ^a,c   Mahmoudi, Hamidreza ^d   Saeidian, Amir Hossein ^a   Daneshpazhooh, Maryam ^d   Kamyab Hesari, Kambiz ^d   Zeinali, Sirous ^c,e   de Jong, Sarah Jill ^f   Orth, Gérard ^g   Blanchet Bardon, Claudine ^h   Jouanguy, Emmanuelle ^f,i,j   Casanova, Jean Laurent ^f,i,j   Uitto, Jouni ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e Kawsar's Human Genetic Research Center   (Iran)

^f ROCKEFELLER UNIVERSITY   (United States)

^g INSTITUT PASTEUR   (France)

^h SAINT LOUIS HOSPITAL   (France)

ⁱ HÔPITAL NECKER ENFANTS MALADES   (France)

^j UNIVERSITÉ PARIS DESCARTES   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; CELLULAR IMMUNITY; EPIDERMODYSPLASIA VERRUCIFORMIS; EVER 1 GENE; EVER 2 GENE; GENE; GENE MUTATION; GENETIC HETEROGENEITY; GENOME-WIDE ASSOCIATION STUDY; HUMAN; INFECTION SENSITIVITY; KERATINOCYTE; NON MELANOMA SKIN CANCER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; WHOLE EXOME SEQUENCING; ADOLESCENT; ADULT; CHILD; DNA MUTATIONAL ANALYSIS; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED; MUTATION; PEDIGREE; STOP CODON; YOUNG ADULT;

DNA; MEMBRANE PROTEIN; TMC6 PROTEIN, HUMAN; TMC8 PROTEIN, HUMAN;

ADOLESCENT; ADULT; CHILD; CODON, NONSENSE; DNA; DNA MUTATIONAL ANALYSIS; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; GENETIC HETEROGENEITY; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; PEDIGREE; YOUNG ADULT;

EID: 85054428682     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1016/j.jid.2018.07.010     Document Type: Article

References (15)

1. Crequer, A., Picard, C., Patin, E., D'Amico, A., Abhyankar, A., Munzer, M., et al. Inherited MST1 deficiency underlies susceptibility to EV-HPV infections. PLoS One, 7, 2012, e44010.
2. de Jong, S.J., Imahorn, E., Itin, P., Uitto, J., Orth, G., Jouanguy, E., et al. Epidermodysplasia verruciformis: inborn erros of immunity of human beta-papillomaviruses. Front Microbiol, 9, 2018, 1222.
3. de Jong SJ, Crequer A, Matos I, Hum D, Gunasekharan V, Lorenzo L, et al. The human CIB1-EVER1-EVER2 complex governs keratinocyte-intrinsic immunity to betapapillomaviruses. J Exp Med 2018b;215:2289-2310.
4. Imahorn, E., Yuksel, Z., Spoerri, I., Gurel, G., Imhof, C., Saracoglu, Z.N., et al. Novel TMC8 splice site mutation in epidermodysplasia verruciformis and review of HPV infections in patients with the disease. J Eur Acad Dermatol Venereol 31 (2017), 1722–1726.
5. Laffort, C., Le Deist, F., Favre, M., Caillat-Zucman, S., Radford-Weiss, I., Debre, M., et al. Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gammac cytokine receptor subunit or JAK-3 deficiency. Lancet 363 (2004), 2051–2054.
6. Li, H., Durbin, R., Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformactics 25 (2009), 1754–1760.
7. Lutzner, M.A., Blanchet-Bardon, C., Orth, G., Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses. J Invest Dermatol 83 (1984), 18s–25s.
8. Notarangelo, L., Casanova, J.L., Fischer, A., Puck, J., Rosen, F., Seger, R., et al. Primary immunodeficiency diseases: an update. J Allergy Clin Immunol 114 (2004), 677–687.
9. Orth, G., Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis. Curr Top Microbiol Immunol 321 (2008), 59–83.
10. Ramoz, N., Rueda, L.A., Bouadjar, B., Montoya, L.S., Orth, G., Favre, M., Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 32 (2002), 579–581.
11. Rogers, H.D., Macgregor, J.L., Nord, K.M., Tyring, S., Rady, P., Engler, D.E., et al. Acquired epidermodysplasia verruciformis. J Am Acad Dermatol 60 (2009), 315–320.
12. Uitto, J., Vahidnezhad, H., Expanding genetics and phenotypic spectrum of epidermodysplasia verruciformis. Br J Dermatol 175 (2016), 1138–1139.
13. Vahidnezhad, H., Youssefian, L., Jazayeri, A., Uitto, J., Research techniques made simple: genome-wide homozygosity/autozygosity mapping is a powerful tool to identify candidate genes in autosomal recessive genetic diseases. J Invest Dermatol 138 (2018), 1893–1900.
14. Vahidnezhad, H., Youssefian, L., Saeidian, A.H., Zeinali, S., Abiri, M., Sotoudeh, S., et al. Genome-wide single nucleotide polymorphism-based autozygosity mapping facilitates identification of mutations in consanguineous families with epidermolysis bullosa. Exp Derm 138 (2018), 121–131.
15. Youssefian, L., Vahidnezhad, H., Majhmoudi, H., Saeidian, A.H., Aghazadeh, N., Sotoudeh, S., et al. Homozygous mutation in ITK associated with monogenic inborn errors of immunity underlies susceptibility to human papilloma virus infections (epidermodysplasia verruciformis). J Invest Dermatol, 137(Suppl. 1), 2017, S110.